Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: A pilot clinical trial

Breast Cancer Research

Volumn 12, Issue 5, 2010, Pages

  Nesaretnam, Kalanithi ^a   Selvaduray, Kanga Rani ^a   Abdul Razak, Ghazali ^a   Veerasenan, Sheela Devi ^a   Gomez, Patricia A ^b  

^a MALAYSIAN PALM OIL BOARD   (Malaysia)

^b HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ESTROGEN RECEPTOR; PLACEBO; TAMOXIFEN; ANTINEOPLASTIC AGENT; ANTIOXIDANT;

ADJUVANT THERAPY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; SIDE EFFECT; TREATMENT DURATION; VITAMIN BLOOD LEVEL; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN; TAMOXIFEN; TOCOTRIENOLS; TREATMENT OUTCOME;

EID: 77957594379     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2726     Document Type: Article

References (16)

1. Ingram DM, Nottager E, Roberts T. The role of diet in the development of breast cancer: a case control study of patients with breast cancer, benign epithelial hyperplasia and fibtrocystic disease of the breast. Br J Cancer 1991, 64:187-191. 1977336, 1854621.
2. Ong ASH. Natural sources of tocotrienols in vitamin E in health and disease. 1993, 3-8. New York: Marcel Dekker, Packer L, Fuchs J.
3. McIntyre BS, Briski KP, Gapor A, Sylvester PW. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 2000, 224:292-301. 10.1046/j.1525-1373.2000.22434.x, 10964265.
4. McIntyre BS, Briski KP, Tirmenstein MA, Fariss AMW, Gapor A, Sylvester PW. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 2000, 35:171-180. 10.1007/BF02664767, 10757548.
5. Komiyama K, Iizuka K, Yamaoka M, Watanabe H, Tsuchiya N, Umezawa I. Studies on the biological activity of tocotrienols. Chem Pharm Bull 1989, 37:1369-1371.
6. Nesaretnam K, Guthrie N, Chambers AF, Caroll KK. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 1995, 30:1139-1143. 10.1007/BF02536615, 8614304.
7. Nesaretnam K, Stephen R, Dils R, Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 1998, 33:461-469. 10.1007/s11745-998-0229-3, 9625593.
8. Nesaretnam K, Dorasamy S, Darbe PD. Tocotrienols inhibit growth of ZR-75-1 mammary cancer cells. Int J Food Sci Nutr 2000, 51:S95-S103. 10.1080/096374800750049611, 11271861.
9. Eitsuka T, Nakagawa K, Miyazawa T. Down-regulation of telomerase activity in DLD- 1 human colorectal adenocarcinoma cells by tocotrienol. BBRC 2006, 348:170-175.
10. Nesaretnam K. Multitargeted therapy of cancer by tocotrienols. Cancer Lett 2008, 269:388-395. 10.1016/j.canlet.2008.03.063, 18504069.
11. Guthrie N, Gapor A, Chambers A, Carroll KK. Inhibition of proliferation of estrogen receptor negative MDA-MB-435 and positive MCF-7 human breast cancer cells by palm tocotrienols and tamoxifen, alone or in combination. J Nutr 1997, 127:544S-548S.
12. Yu W, Simmons-Menchala M, Gapor A, Sanders G, Kline K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 1999, 33:26-32. 10.1080/01635589909514744, 10227040.
13. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655. 10.1097/00000421-198212000-00014, 7165009.
14. Comitato R, Nesaretnam K, Leoni G, Ambra R, Canali R, Bolli A, Marino M, Virgili F. A novel mechanism of natural vitamin E tocotrienol activity: involvement of ERbeta signal transduction. Am J Physiol Endocrinol Metab 2009, 297:E427-E437. 10.1152/ajpendo.00187.2009, 19491296.
15. Jiang Q, Christen S, Shigenaga MK, Ames BN. γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001, 74:714-722.
16. Khosla P, Patel V, Whinter JM, Khanna S, Rakhkovskaya M, Roy S, Sen CK. Postprandial levels of natural vitamin E tocotrienol in human circulation. Antioxid Redox Signal 2006, 8:1059-1068. 10.1089/ars.2006.8.1059, 16771695.